Search This Blog

Monday, June 3, 2019

Trevi started at Buy by Needham

Target $18

Trevi started at Outperform by BMO

Target $15

Trevi started at Buy by Stifel

Target $20

Teva upped to Outperform by Oppenheimer

From Perform; target $12

NextCure started at Overweight by Morgan Stanley

Target $25

NextCure started at Overweight by Piper Jaffray

Target $26.

Molina upped to Outperform by BMO

From Market Perform; target to $200 from $154.